Chemokine receptor CCR1 antagonist CCX354-C treatment for rheumatoid arthritis: CARAT-2, a randomised, placebo controlled clinical trial

201298 citationsJournal Article

Authors

Good health and well-being

Published in: Annals of the Rheumatic Diseases

Volume 72, Issue 3, pp. 337-344

Field-Weighted Citation Impact: 5.89